Tycel Jovelle Phillips

机构：City Of Hope National Medical Center, City of Hope · ORCID：0000-0003-2143-9672

发表论文 359 篇 · 总被引 4532 次 · h-index 35

代表论文

• Mosunetuzumab plus Pola-CHP compared with Pola-R-CHP in previously untreated DLBCL: final results from a phase 2 study (2025 · Blood Advances · 被引 15)
• Real-world comparative effectiveness of Bruton tyrosine kinase inhibitors in relapsed/refractory mantle cell lymphoma (2025 · Blood Advances · 被引 6)
• Interim analysis of the phase II study of glofitamab, lenaliomide and venetoclax (GLOVe) in untreated patients w/ high-risk mantle cell lymphoma. response and safety outcomes after the completion of stage 1 of 2 enrollment. (2025 · Blood · 被引 6)
• The Current State of Bispecific Antibodies and T-Cell Directed Therapy in NHL (2025 · Cancers · 被引 5)
• Understanding the Functional Dependence and Inhibition of the Bcl-2 Pro-Survival Proteins in a Wide Spectrum of Cancers toward Precision Medicine (2025 · ACS Pharmacology & Translational Science · 被引 3)
• Cost effectiveness of mosunetuzumab and CAR-T cell therapy in relapsed/refractory follicular lymphoma (2025 · Leukemia & lymphoma/Leukemia and lymphoma · 被引 2)